Dr. Peter H. Lin, MD

Dr. Lin practices at Valley Digestive Health Center in Arcadia, California.

Dr. Lin's NPI, 1982784625, was assigned on October 17, 2006. Dr. Lin graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1992. Dr. Lin holds California license G135687.

Dr. Lin's primary practice is Valley Digestive Health Center, at 488 Santa Clara Street, Suite 102, Arcadia, CA 91006. The practice phone is (626) 359-9555.

Dr. Lin's primary practice is Valley Digestive Health Center in Arcadia, California. Dr. Lin is also affiliated with USC Arcadia Hospital. The medical group on file is Vascular Care Specialists. Dmand AI also links Dr. Lin to 3 more hospitals, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 7 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Lin is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Lin's licenses on file in 4 states: California, Texas, Georgia and Illinois.

Dmand AI lists amputation, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery, leg revascularization and peripheral vascular disease among the conditions Dr. Lin treats.

CMS data shows 3,661 Medicare services from Dr. Lin across 34 procedure codes in 2024, for 509 Medicare patients. Medicare paid $1,903,714 for them.

CMS counts 509 Medicare patients who saw Dr. Lin in 2024. The largest group is 75 to 84, with 183 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 72% are also on Medicaid. Their average risk score is 3.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 71, with 55% women.

In 2024, Dr. Lin wrote 26 Medicare Part D claims for 20 patients. 85% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $39 in total drug cost.

Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 68 procedures of leg revascularization (restoring blood flow) by Dr. Lin, more than 97% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 271 papers to Dr. Lin, published from 2002 to 2018. 2017 was the busiest year, with 13. The most frequent topics are Stents, Blood Vessel Prosthesis Implantation and Aortic Aneurysm, Abdominal. Dr. Lin has published most often in J Vasc Surg. Dr. Lin's most frequent co-authors are Alan B. Lumsden, MD, Ruth L. Bush, MD and Panagiotis Kougias, MD.

CMS Open Payments shows 40 general payments to Dr. Lin from 11 drug and device companies from 2024 to 2025. Device or supply loans make up the largest share, 94% of the total. AngioDynamics, Inc. paid the most, $15,178.

Dmand AI lists 2 awards for Dr. Lin, most recently CMS Stage 1 EHR in 2013.

Dr. Lin graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1992. Dr. Lin is a member of ACS and SVS.

Dr. Lin is in network with 15 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.